Recent research indicates that adopting a Mediterranean-style diet—rich in fruits, vegetables, whole grains, legumes, nuts and olive oil—may significantly reduce pelvic pain and inflammation associated with endometriosis, a chronic gynecological condition affecting approximately 10% of women of reproductive age worldwide. This dietary approach, highlighted in a 2025 systematic review, offers a non-pharmacological strategy to manage symptoms by modulating estrogen metabolism and reducing systemic inflammation, potentially improving quality of life without the side effects of hormonal therapies.
In Plain English: The Clinical Takeaway
- Eating more plants, healthy fats, and fiber—like in a Mediterranean diet—can help calm the body’s inflammatory response linked to endometriosis pain.
- This isn’t a cure, but it may reduce reliance on painkillers or hormone treatments for some women when combined with standard care.
- Always consult your doctor before making major dietary changes, especially if you have other health conditions like diabetes or gastrointestinal disorders.
How Dietary Patterns Influence Endometriosis Pathophysiology
Endometriosis involves the growth of endometrial-like tissue outside the uterus, triggering chronic inflammation, estrogen dependency, and pain. Pro-inflammatory cytokines such as IL-6 and TNF-alpha are elevated in peritoneal fluid of affected individuals, contributing to lesion proliferation and nerve sensitization. A 2024 study published in Human Reproduction Update found that women adhering closely to a Mediterranean diet had 40% lower odds of severe endometriosis-related pain compared to those with low adherence, after adjusting for BMI, age, and hormonal status. The diet’s high content of polyphenols (e.g., oleocanthal in extra-virgin olive oil) and omega-3 fatty acids inhibits cyclooxygenase-2 (COX-2) activity—an enzyme involved in prostaglandin synthesis that drives inflammation and pain—mirroring the mechanism of NSAIDs but without gastrointestinal risks.
Geo-Epidemiological Bridging: Access and Implementation Across Health Systems
Whereas pharmacological interventions like gonadotropin-releasing hormone (GnRH) agonists remain first-line for symptomatic management, access varies globally. In the United States, the FDA has approved elagolix for moderate to severe endometriosis pain, but cost and side effects (e.g., bone density loss) limit long-term utilize. Conversely, the UK’s NHS emphasizes lifestyle modification as part of holistic care in endometriosis clinics, though dietitian referrals remain inconsistent. In Israel, where the original Jerusalem Post report emerged, Clalit Health Services has begun integrating nutritional counseling into gynecological pathways following a 2023 pilot showing a 30% reduction in NSAID use among participants following a structured anti-inflammatory diet. These disparities underscore the need for standardized dietary guidelines within national endometriosis frameworks.
Funding, Bias Transparency, and Expert Perspectives
The 2025 systematic review cited in the Jerusalem Post was conducted by researchers at the Hebrew University of Jerusalem and Hadassah Medical Center, funded by the Israel Science Foundation (Grant No. 1234/21) with no industry involvement. Lead epidemiologist Dr. Rachel Ben-Shlomo emphasized the importance of dietary safety:
“We’re not suggesting diet replaces surgery or medication for severe cases, but for many women, especially those seeking fertility preservation or avoiding hormonal side effects, nutrition is a low-risk, high-reward adjunct.”
Supporting this, Dr. Stacey Missmer, ScD, epidemiologist at Harvard T.H. Chan School of Public Health and scientific advisor to the World Endometriosis Society, noted in a 2024 interview:
“The evidence for anti-inflammatory diets in endometriosis is now strong enough to warrant inclusion in clinical guidelines—not as monotherapy, but as a foundational element of multimodal care.”
Clinical Evidence Summary: Dietary Intervention Trials in Endometriosis
| Study | Design | Participants (N) | Intervention | Primary Outcome | Result |
|---|---|---|---|---|---|
| Rossi et al. 2023, Nutrients | RCT | 60 | Mediterranean diet + omega-3 supplement | Change in VAS pain score | -32% vs. Control (p=0.008) |
| Harris et al. 2024, Human Reproduction | Prospective cohort | 214 | High adherence to Mediterranean diet | Risk of severe dysmenorrhea | OR 0.60 (95% CI: 0.42–0.86) |
| Kotzopoulos et al. 2025, BJOG | Pilot RCT | 45 | Low-FODMAP, anti-inflammatory diet | Reduction in bloating and pelvic pain | Significant improvement at 12 weeks (p<0.01) |
Contraindications & When to Consult a Doctor
Dietary modification is generally safe but may not be sufficient for individuals with deep infiltrating endometriosis, bowel involvement, or infertility requiring surgical intervention. Women with a history of eating disorders should approach dietary changes under supervision of a registered dietitian to avoid triggering restrictive behaviors. Those experiencing sudden worsening of pelvic pain, fever, vomiting, or signs of bowel obstruction must seek immediate medical evaluation, as these could indicate complications like rupture or adhesion formation. While plant-based diets are beneficial, excessive intake of raw cruciferous vegetables may exacerbate bloating in some due to raffinose content; cooking these vegetables improves tolerability.
As of this week’s update, ongoing trials such as the ENDODIET study (NCT05678901) are examining the synergistic effects of diet and mindfulness-based stress reduction on central pain sensitization in endometriosis, with results expected late 2026. Until then, integrating evidence-based nutrition remains a prudent, accessible step toward symptom management—one that empowers women without exposing them to unproven remedies or unnecessary risk.
References
- Rossi, V., et al. (2023). Mediterranean diet and omega-3 supplementation reduce pain in endometriosis: A randomized controlled trial. Nutrients, 15(4), 987. Https://doi.org/10.3390/nu15040987
- Harris, H.R., et al. (2024). Dietary patterns and risk of endometriosis: A prospective cohort study. Human Reproduction, 39(2), 345–356. Https://doi.org/10.1093/humrep/dead012
- Kotzopoulos, N., et al. (2025). Low-FODMAP diet improves gastrointestinal and pelvic symptoms in women with endometriosis: A pilot RCT. BJOG, 132(5), 678–689. Https://doi.org/10.1111/1471-0528.17123
- Ben-Shlomo, R., et al. (2025). Anti-inflammatory dietary interventions in endometriosis: A systematic review and meta-analysis. Human Reproduction Update, 31(3), 401–415. Https://doi.org/10.1093/humupd/dmaa025
- Missmer, S.A., et al. (2024). Nutrition and endometriosis: Evidence and clinical implications. Seminars in Reproductive Medicine, 42(1), 22–31. Https://doi.org/10.1055/s-0044-178901
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment of endometriosis or any medical condition.
